Map Pharma will issue 86 million U.S. dollars of initial shares
From: MarketWatch
Monday disc, Map Pharmaceuticals Inc.. SEC to submit the registration statement, will issue 862.5 billion U.S. dollars initial shares of its initial shares Underwriters will be Morgan Stanley and Merrill Lynch.
Map Pharmaceuticals Inc.. Company headquarters in California Mounta in View, is a production of inhaled asthma and migraine drug manufacturers. The company plans to the Nasdaq “MAPP” code listed transactions.
Map Pharmaceuticals Inc.. Company shareholders including Perseus-Soro ’s Biopharmaceutical Fund, L.P., Pequot Private Equity Fund III, L.P. and Brookside Capital Partners Fund, Limited, and so on.
Copyright Fund China 2009.
You Might Like:
You must be logged in to post a comment.